Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02357277Phase 4Withdrawn
Phase 4, randomised, double-blind trial of budesonide in asthma (3 arms), sponsored by Columbia University. Primary endpoint: Change in Osteocalcin at 4 weeks. Planned start Mar 2015; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02357277.